1594/2025 - Ajuste direto para aquisição de O4 - OCTREOTIDO [0,1 MG/1ML; F/AMP]

ID 12237122 · Portal BASE
Price
Base Price
€20,613 .00
Effective Price
€3,546 .00 -82.8%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Viseu, Viseu
Bidder Count
—
Winner
PHARMIS BIOFARMACÊUTICA LDA
NIF 502595442
Company
Dates
Publication
30 Dec 2025
Celebration
23 Jun 2025
Contracting Entity
Centro Hospitalar Tondela-Viseu, EPE
NIF 509822940
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
264
Supplier
118
Number of Awards
3
Rule
A1 repeat direct award: 3 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
30 Dec 2025
Signing Date
23 Jun 2025
Days Late
190
Rule
A2/A3 late publication: 190 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
20613.0
Total effective price
3546.0
Ratio
0.172
Direction
reduction
Rule
A9 price reduction: ratio 0.172 outside [0.5, 1.5]
Detected 2026-03-06